sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Wed Dec 17
Silver Falls After Trump Holds Off on Critical Mineral Tariffs
1d
Y
Here’s What Analysts Think About Banco Bilbao Vizcaya Argentaria (BBVA)
1d
Y
What Does Wall Street Think About Banco Santander (SAN)?
1d
Y
Why is Equinor ASA (EQNR) One of the Best Affordable Stocks Under $30?
1d
Y
Piper Believes Stellantis N.V. (STLA) Has the Potential for “Rapid Upside” – Here’s Why
1d
Y
Barclays Maintains Overweight Rating on Energy Transfer LP (ET)
1d
Y
Where is Vale S.A. (VALE) Headed According to Analysts?
1d
Y
This is What Analysts Are Saying About Cenovus Energy Inc. (CVE)
1d
Y
Where is JD.com (JD) Headed According to the Street?
1d
Y
Why Pfizer Inc. (PFE) is One of the Best Affordable Stocks Under $30
1d
Y
2 Top Artificial Intelligence (AI) Stocks Ready for a Bull Run
1d
Y
Here is What Analysts Think About AT&T Inc. (T)
1d
Y
Here’s What Analysts Think About Fortinet (FTNT)
1d
Y
What Do Analysts Think About KLA Corporation (KLAC)?
1d
Y
Where is Palantir Technologies Inc. (PLTR) Headed According to Analysts?
1d
Y
This is What Analysts Think About Arista Networks (ANET)
1d
Y
What Does Wall Street Think About ServiceNow (NOW)?
1d
Y
Where is Eli Lilly and Company (LLY) Headed According to Analysts?
1d
Y
Is Advanced Micro Devices (AMD) One of the Best Long Term Growth Stocks to Buy According to Hedge Funds?
1d
Y
This is What The Street Thinks About Uber Technologies (UBER)
1d
Y
OpenAI Seeks US-Based Suppliers for Planned Robotics, AI Device Push
1d
Y
What's Driving This Week's Market Swings? It Could Be Inflation.
1d
Y
Alphatec Holdings, Inc. (ATEC) Shares Preliminary 2025 Results and 2026 Outlook
1d
Y
Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN)
1d
Y
Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why
1d
Y
Edgewise Therapeutics, Inc. (EWTX) Outlines Priorities For 2026
1d
Y
Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside
1d
Y
Vera Therapeutics, Inc. (VERA) Granted FDA Priority Review For Atacicept
1d
Y
Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral
1d
Y
Is Immunome, Inc. (IMNM) The Best Booming Stock To Buy Right Now?
1d
Y
Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus
1d
Y
Wall Street Bullish on Spyre Therapeutics, Inc. (SYRE) with Strong Buy Rating
1d
Y
Nuvation Bio Inc. (NUVB) Announces Exclusive Licensing Agreement With Eisai to Expand Global Reach of Taletrectinib
1d
Y
HC Wainwright & Co. Hikes Alumis Inc. (ALMS)’s Price Target To $40 From $20, Reiterates Buy Rating
1d
Y
Analysts Project 120% Upside To Dyne Therapeutics, Inc. (DYN)
1d
Y
Senate Dems To Discuss Clarity Act Concerns With Crypto Representatives
1d
Y
Silver Prices Keep Confounding Experts. I Won’t Be Surprised If They Hit $100 Soon.
1d
Y
Silver surge masks quiet risk
1d
Y
MrBeast Eyes DeFi as Tom Lee's Ethereum Treasury BitMine Invests $200 Million
1d
Y
I Was Right About Interest Rates in 2025. Here's What I Think Will Happen in 2026.
1d
Y
3 Technology Stocks to Sell in 2026
1d
Y
Jamie Dimon’s High-Wire Act Runs Into Trouble
1d
Y
Noodles & Company is closing 30 more restaurants: List of doomed locations grows in 2026
1d
Y
2 Cheap Mid-Cap Growth Stocks That Can Benefit From Lower Interest Rates
1d
Y
Labor, tariffs collide with data center boom
1d
Y
Aramark Told to Sell Entier by U.K. Merger Watchdog
1d
Y
CME Group to Launch Cardano, Chainlink, Stellar Futures on Feb 9
1d
Y
European corporates expected to deliver worst earnings growth in past seven quarters
1d
Y
Stocks Supported by Strength in Chip Makers and US Economic News
1d
Y
Legendary Investor Michael Burry Is Betting Against Oracle Stock. What You Need to Know About the Bear Case for ORCL.
1d
Y
More →